Psoriasis study: Duobrii
Official title Duobrii in Combination With Biologics
ClinicalTrials.gov ID: NCT04119102
What this study is testing
What is Duobrii?
Duobrii is an investigational topical drug being studied as a potential treatment for psoriasis.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether adding Duobrii to a biologic medicine helps treat psoriasis.
- Who it's for
- You may be able to join if you have psoriasis covering 2% to 10% of your skin and have been on a biologic medicine for at least 24 weeks.
- What's involved
- You will take Duobrii for 12 weeks while continuing your biologic medicine. You will have visits to check your skin and any side effects.
- Time commitment
- The study lasts 12 weeks and includes regular check‑in visits during that time.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female adult ≥ 18 years of age;
- Diagnosis of chronic plaque-type
- Psoriasis affecting 2%-10% BSA
- Patient is being treated with biologic therapy for a minimum of 24 weeks
- Able and willing to give written informed consent prior to performance of any study-related procedures
You likely can't join if
- Psoriasis affecting ˂2% or \>10% BSA
- Patient not receiving a biologic agent, or receiving biologic agent \<24weeks
- Received treatment with any topical antipsoriatic drug product within 14 days prior to the Baseline visit.
- Has previously used DUOBRII
The study team makes the final eligibility decision.
Where it is enrolling
- East Windsor, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at East Windsor, New Jersey, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.